Cell Adhesion Molecules are Upregulated and May Drive Inflammation in Chronic Rhinosinusitis with Nasal Polyposis

References

• Mitroulis I, Alexaki VI, Kourtzelis I, Ziogas A, Hajishengallis G, Chavakis T. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther. 2015;147:123–135.
   PubMed Web of Science ®Google Scholar
• Fagerholm SC, Guenther C, Llort Asens M, Savinko T, Uotila LM. Beta2-integrins and interacting proteins in leukocyte trafficking, immune suppression, and immunodeficiency disease. Front Immunol. 2019;10:254. doi:10.3389/fimmu.2019.00254
   PubMed Web of Science ®Google Scholar
• Yee NK, Hamerman JA. beta(2) integrins inhibit TLR responses by regulating NF-kappaB pathway and p38 MAPK activation. Eur J Immunol. 2013;43:779–792. doi:10.1002/eji.201242550
   Web of Science ®Google Scholar
• Chen X, Corry DB, Li E. Mechanisms of allergy and adult asthma. Curr Opin Allergy Clin Immunol. 2020;20:36–42. doi:10.1097/ACI.0000000000000601
   Web of Science ®Google Scholar
• Lees KR, Diener HC, Asplund K, Krams M. UK-279,276, a neutrophil inhibitory glycoprotein, in acute stroke: tolerability and pharmacokinetics. Stroke. 2003;34:1704–1709. doi:10.1161/01.STR.0000078563.72650.61
   Web of Science ®Google Scholar
• Liu M, Guo P, An J, Guo C, Lu F, Lei Y. Genomewide profiling of lncRNA and mRNA expression in CRSwNP. Mol Med Rep. 2019;19:3855–3863. doi:10.3892/mmr.2019.10005
   Web of Science ®Google Scholar
• McLean LP, Cross RK. Integrin antagonists as potential therapeutic options for the treatment of Crohn’s disease. Expert Opin Investig Drugs. 2016;25:263–273. doi:10.1517/13543784.2016.1148137
   PubMed Web of Science ®Google Scholar
• Singh H, Grewal N, Arora E, Kumar H, Kakkar AK. Vedolizumab: a novel anti-integrin drug for treatment of inflammatory bowel disease. J Nat Sci Biol Med. 2016;7:4–9. doi:10.4103/0976-9668.175016
   Google Scholar
• Douglas IS, Leff AR, Sperling AI. CD4+ T cell and eosinophil adhesion is mediated by specific ICAM-3 ligation and results in eosinophil activation. J Immunol. 2000;164:3385–3391. doi:10.4049/jimmunol.164.6.3385
   PubMed Web of Science ®Google Scholar
• Gascoigne MH, Holland K, Page CP, et al. The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits. Pulm Pharmacol Ther. 2003;16:279–285. doi:10.1016/S1094-5539(03)00069-5
   Web of Science ®Google Scholar
• Gu P, Theiss A, Han J, Feagins LA. Increased cell adhesion molecules, PECAM-1, ICAM-3, or VCAM-1, predict increased risk for flare in patients with quiescent inflammatory bowel disease. J Clin Gastroenterol. 2017;51:522–527. doi:10.1097/MCG.0000000000000618
   Web of Science ®Google Scholar
• Karta MR, Rosenthal PS, Beppu A, et al. β2 integrins rather than β1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung. J Allergy Clin Immunol. 2018;141:329–338 e312. doi:10.1016/j.jaci.2017.03.010
   Web of Science ®Google Scholar
• Vainer B, Nielsen OH, Horn T. Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, −2, and −3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn’s disease. Am J Surg Pathol. 2000;24:1115–1124. doi:10.1097/00000478-200008000-00009
   PubMed Web of Science ®Google Scholar
• Koennecke M, Klimek L, Mullol J, Gevaert P, Wollenberg B. Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities. Allergo J Int. 2018;27:56–65. doi:10.1007/s40629-017-0048-5
   Google Scholar
• Shin HW, Kim DK, Park MH, et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2015;135:1476–1485 e1477. doi:10.1016/j.jaci.2015.01.003
   PubMed Web of Science ®Google Scholar
• Oyer SL, Nagel W, Mulligan JK. Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients. Am J Rhinol Allergy. 2013;27:381–386. doi:10.2500/ajra.2013.27.3934
   Web of Science ®Google Scholar
• Cao PP, Wang ZC, Schleimer RP, Liu Z. Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Ann Allergy Asthma Immunol. 2019;122:33–40. doi:10.1016/j.anai.2018.10.014
   PubMed Web of Science ®Google Scholar
• Rosati MG, Peters AT. Relationships among allergic rhinitis, asthma, and chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30:44–47. doi:10.2500/ajra.2016.30.4252
   Web of Science ®Google Scholar
• Becker KL, Gresnigt MS, Smeekens SP, et al. Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. Clin Exp Allergy. 2015;45:423–437. doi:10.1111/cea.12354
   PubMed Web of Science ®Google Scholar
• Cheung PF, Wong CK, Ip WK, Lam CW. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy. 2006;61:878–885. doi:10.1111/j.1398-9995.2006.01102.x
   Web of Science ®Google Scholar
• Chung SD, Chen PY, Lin HC, Hung SH. Comorbidity profile of chronic rhinosinusitis: a population-based study. Laryngoscope. 2014;124:1536–1541. doi:10.1002/lary.24581
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg. 2007;137:365–377. doi:10.1016/j.otohns.2007.07.021
   PubMed Web of Science ®Google Scholar
• Brumbaugh CD, Kim HJ, Giovacchini M, Pourmand N. NanoStriDE: normalization and differential expression analysis of NanoString nCounter data. BMC Bioinform. 2011;12:479. doi:10.1186/1471-2105-12-479
   PubMed Web of Science ®Google Scholar
• Kulkarni MM. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr Protoc Mol Biol. 2011;94:25B–10.
   Google Scholar
• Wickham H. Ggplot2: Elegant Graphics for Data Analysis. Springer: New York; 2009.
   Google Scholar
• Johansson MW, Annis DS, Mosher DF. αMβ2 integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. Am J Respir Cell Mol Biol. 2013;48:503–510. doi:10.1165/rcmb.2012-0150OC
   PubMed Web of Science ®Google Scholar
• Vorup-Jensen T, Jensen RK. Structural immunology of complement receptors 3 and 4. Front Immunol. 2018;9:2716. doi:10.3389/fimmu.2018.02716
   Web of Science ®Google Scholar
• Fischer E, Capron M, Prin L, Kusnierz JP, Kazatchkine MD. Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol. 1986;97:297–306. doi:10.1016/0008-8749(86)90400-4
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Campbell KD, Skubitz AP. CD50 monoclonal antibodies inhibit neutrophil activation. J Immunol. 1997;159:820–828.
   Web of Science ®Google Scholar
• Hua S. Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies. Front Pharmacol. 2013;4:127. doi:10.3389/fphar.2013.00127
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–687. doi:10.1016/S0092-8674(02)00971-6
   PubMed Web of Science ®Google Scholar